290 results on '"Thomas, Reena"'
Search Results
2. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
3. Brain Edema and Corticosteroid Toxicity
4. Underrepresented in Medicine Trainees’ Sense of Belonging and Professional Identity Formation after Participation in the Leadership Education in Advancing Diversity Program
5. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)
6. A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma.
7. Extraction of Unstructured Electronic Health Records to Evaluate Glioblastoma Treatment Patterns
8. Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide
9. A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes
10. Differential Glioma Mortality and Grading in Disaggregated Asian American Subgroups: Insights from SEER 2000–2020 (P4-5.014)
11. Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking (P4-5.010)
12. Suicide, Stimulants, and Selective Serotonin Reuptake Inhibitors: A Retrospective Chart Review
13. Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
14. Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
15. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
16. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
17. Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma
18. Quality of Life of End Stage Renal Disease Patients Undergoing Dialysis in Southern Part of Kerala, India: Financial Stability and Inter-dialysis Weight Gain as Key Determinants
19. Nodular Leptomeningeal Disease—A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability
20. Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma
21. Selective prediction for extracting unstructured clinical data
22. Neurological adverse effects due to programmed death 1 (PD-1) inhibitors
23. Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma.
24. Selective prediction for extracting unstructured clinical data.
25. Data-driven extraction of unstructured electronic health records to evaluate glioblastoma treatment patterns
26. 890 Disparities in Supportive Care Utilization Among Neurosurgical Patients With Malignant Central Nervous System Tumors
27. Supplementary Figure S6 from A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
28. Supplementary Table S5 from A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
29. Cultural Hybridity
30. Rooting out racial stereotypes in Neurology®: A commentary on “Lucky and the root doctor”
31. Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
32. Design and Fabrication of Metallic-Conductive Polymer-Based Hybrid Film Interconnections for Stretchable Electronic Devices
33. Selective prediction for extracting unstructured clinical data
34. Continuous EEG monitoring detects nonconvulsive seizure and Ictal-Interictal Continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy
35. Psychosis After Infection With SARS-CoV-2 in an Adolescent: A Case Report
36. Modifiers of and Disparities in Palliative and Supportive Care Timing and Utilization among Neurosurgical Patients with Malignant Central Nervous System Tumors
37. Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma
38. Treatment Options for Optic Pathway Gliomas
39. 73 - Clinical Features of Brain Tumors and Complications of Their Treatment
40. Evaluation of Hypercalcemia in Infancy
41. Acute Upper Airway Obstruction as Atypical Manifestation of Uncommon Aetiologies- A Case Series
42. Microbiology and clinical outcomes of central venous catheter-related blood stream infections in patients on maintenance hemodialysis
43. Contourlet and Gould Transforms for Hybrid Image Watermarking in RGB Color Images
44. Outcomes From a Novel Graduate Medical Education Leadership Program in Advancing Diversity, Equity, and Inclusion
45. A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
46. Diversifying Healthcare Through Stanford's Minority Medical Alliance 32nd Prehealth Conference.
47. Continuous EEG monitoring detects nonconvulsive seizure and Ictal-Interictal Continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy
48. The incidence and significance of multiple lesions in glioblastoma
49. Recurrent Status Epilepticus in the Setting of Chimeric Antigen Receptor (CAR)-T Cell Therapy
50. BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.